Targeted Integration Through Transformation of Hydroxyurea-Arrested Cells
1Ginkgo Bioworks, Boston, MA, USA. vtsakraklides@ginkgobioworks.com.
Methods in Molecular Biology (Clifton, N.J.)
|April 13, 2021
Summary
Targeted DNA integration in Yarrowia lipolytica is enhanced by hydroxyurea treatment. This method increases homologous recombination rates, improving precise DNA insertion into the genome.
Area of Science:
- Molecular Biology
- Genetics
- Microbiology
Background:
- Homologous recombination (HR) is crucial for targeted DNA integration into specific genomic locations.
- Non-homologous end joining (NHEJ) is the primary recombination pathway in Yarrowia lipolytica, leading to random DNA integration.
- Standard transformation methods in Y. lipolytica often result in unpredictable DNA insertion due to the prevalence of NHEJ.
Purpose of the Study:
- To develop a protocol for enhancing targeted DNA integration in Yarrowia lipolytica.
- To increase the efficiency of homologous recombination during the transformation process.
- To overcome the limitations of non-homologous end joining in Y. lipolytica.
Main Methods:
- Utilizing hydroxyurea to induce cell cycle arrest in Yarrowia lipolytica cells.
- Applying the hydroxyurea-mediated arrest prior to or during DNA transformation.
- Evaluating the rate of homologous recombination and targeted DNA integration post-treatment.
Main Results:
- Hydroxyurea treatment significantly increased the frequency of homologous recombination.
- Targeted integration of DNA into the desired genomic locus was substantially enhanced.
- The protocol demonstrated improved precision in DNA insertion compared to standard transformation methods.
Conclusions:
- Hydroxyurea-mediated cell cycle arrest is an effective strategy to promote homologous recombination in Y. lipolytica.
- This protocol offers a reliable method for achieving targeted genomic modifications in Y. lipolytica.
- The findings provide a valuable tool for genetic engineering applications in Y. lipolytica.
Related Concept Videos
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine
5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K


